Almirall SA
F:E2Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Almirall SA
F:E2Z
|
ES |
|
C
|
CVS Health Corp
XBER:CVS
|
US |
|
C
|
Caterpillar Inc
XBER:CAT1
|
US |
|
C
|
Conocophillips
BMV:COP
|
US |
|
M
|
MSA Safety Inc
F:M07
|
US |
|
K
|
Knight-Swift Transportation Holdings Inc
F:KSX
|
US |
|
A
|
AstraZeneca PLC
BMV:AZNN
|
UK |
|
L
|
Liberty Global PLC
NASDAQ:LBTYB
|
UK |
|
N
|
New Gold Inc
XMUN:32N
|
CA |
|
Polski Koncern Naftowy Orlen SA
WSE:PKN
|
PL |
|
Boston Beer Company Inc
NYSE:SAM
|
US |
Wall St Price Targets
E2Z Price Targets Summary
Almirall SA
According to Wall Street analysts, the average 1-year price target for E2Z is 14.51 EUR with a low forecast of 12.23 EUR and a high forecast of 17.79 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is E2Z's stock price target?
Price Target
14.51
EUR
According to Wall Street analysts, the average 1-year price target for E2Z is 14.51 EUR with a low forecast of 12.23 EUR and a high forecast of 17.79 EUR.
What is the Revenue forecast for Almirall SA?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 5 years is 8%.
What is the Operating Income forecast for Almirall SA?
Projected CAGR
30%
Over the last 14 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 5 years is 30%.
What is the Net Income forecast for Almirall SA?
Projected CAGR
36%
Over the last 14 years, the compound annual growth rate for Net Income has been -4%. The projected CAGR for the next 5 years is 36%.
